On October 27, 2025, Eli Lilly announced that the U.S. FDA approved a new, once-monthly single-injection maintenance regimen ...

Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles, marking one ...

Eli Lilly is partnering with Nvidia to construct a supercomputer aimed at accelerating drug discovery and shortening ...

Eli Lilly and tech giant NVIDIA have joined forces on an ambitious plan – building the most powerful AI-powered supercomputer ...

The drugmaker hopes an Nvidia-chip powered supercomputer will help it find new drugs and accelerate lengthy R&D timelines.

Eli Lilly partners with NVIDIA to build a powerful AI supercomputer and teams up with Walmart to expand affordable Zepbound access nationwide.

Lilly and NVIDIA’s supercomputer marks the world's first NVIDIA DGX SuperPOD with DGX B300 systems, and is powered by more than 1,000 B300 GPUs on a unified networking fabric, meaning communication ...

Eli Lilly said it was collaborating with Nvidia to build a supercomputer to help with drug discovery and shorten development ...

Eli Lilly (LLY) and Walmart (WMT) announced a partnership to expand access to Zepbound (tirzepatide) through LillyDirect’s ...

Eli Lilly and Johnson & Johnson are joining fellow Big Pharma peers in upping their investment in AI, with Lilly looking to ...

Eli Lilly and Company said the partnership will result in the build of the most powerful supercomputer owned by a pharmaceutical company.

Bausch Health recently stopped participating in Medicaid and a federal government drug discount program known as 340B ...